The vapor-phase co-reductions with other metal halides by hydrogen results in finely divided intermetallics with applications as structural materials or compounds with useful thermoelectric, magnetic, and oxidation-resistance properties.2
Journal of combinatorial chemistry, 8(6), 881-889 (2006-11-14)
A colorimetric diffusion-reflection imaging (CDRI) high-throughput analytical technology was developed for library analysis. In the investigation, quartz sands were employed as light diffusion-reflection media. Inorganic and organic compounds with characteristic absorption bands in visible light could be quantified by this
Toxicology and applied pharmacology, 161(1), 75-81 (1999-11-24)
Cr(6+) is a known human cytotoxic and carcinogenic agent that requires intracellular reduction for activation. We have analyzed the cytotoxic and DNA binding properties of K(2)CrO(4) (Cr(6+)) in comparison with those of Cl(3)Cr (Cr(3+)). The results indicate that K(2)CrO(4) exhibits
Dalton transactions (Cambridge, England : 2003), (14)(14), 1864-1871 (2008-03-29)
The coordination chemistry of CrCl3 with three pentadentate ligands having the [1,4,7]-triazacyclononane-1,4-diacetato motif have been investigated. The new resulting six-coordinate Cr(iii)-chloro species react cleanly with sodium azide to form the corresponding azido species, which undergo photolysis under irradiation at 419
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 18(3), 394-398 (2012-02-03)
To investigate the effects of intravenous chromium on serum glucose and insulin infusion rates in hospitalized patients with severe insulin resistance. In this retrospective study, we reviewed hospital records from January 1, 2008, to December 1, 2008, to identify patients
Toxicological sciences : an official journal of the Society of Toxicology, 45(1), 72-76 (1998-12-16)
Some compounds of hexavalent chromium are well-established carcinogens. Chromium enters mammalian cells in the hexavalent form and is reduced to chromium (III). Treatment of purified DNA with chromium (III) produces DNA-DNA interstrand crosslinks (DDC) which obstruct the progression of DNA
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
